BD, Medtronic and Abbott were among the top 10 medical device manufacturers with the highest number of late reports, the ...

Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

Discussions covered identifying eligible patients, increasing the number of specialized centers across Egypt’s governorates, ...

The medical device industry is undergoing a profound change in 2025, driven by advancements in generative AI and agentic AI.

New York City’s Mount Sinai has become the first hospital in the US to perform a deep brain stimulation (DBS) implantation ...

People with Parkinson's disease who have a pacemaker-like device implanted in the brain spend an extra four-plus hours a day free of tremors and involuntary movements than they do on medication, ...

简介：Google家在SimCLR自监督对比学习（contrastive learning）的loss结构基础上，延伸到有监督学习中 ...

Disclaimer The DBS team of the AMC received unrestricted research grants from Medtronic and received financial compensation for teaching courses for the European Continue Medical Training (ECMT) ...

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...

Medtronic plc, a Galway-headquartered global leader in healthcare technology, announced the US FDA has approval of BrainSense adaptive Deep Brain Stimulation (aDBS) and BrainSense Electrode Identifier ...